$1.75
-0.05-2.78%
At Close: -
$1.77
0.021.05%
After Hours: 5:35 PM EDT
15 minutes delayed
Comments
Loading...
Bio-Path Hldgs
BPTHNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Bio-Path Hldgs (NASDAQ:BPTH) Stock, Analyst Ratings, Price Targets, Forecasts
Bio-Path Holdings Inc has a consensus price target of $23 based on the ratings of 3 analysts. The high is $40 issued by Roth MKM on March 27, 2024. The low is $9 issued by HC Wainwright & Co. on May 19, 2022. The 3 most-recent analyst ratings were released by Roth MKM on July 8, 2024, April 18, 2024, and March 27, 2024, respectively. With an average price target of $33.33 between Roth MKM, there's an implied 1785.05% upside for Bio-Path Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Roth MKM
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Bio-Path Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | Buy Now | 1031.03% | Roth MKM | Philip Shen | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 04/18/2024 | Buy Now | 2162.06% | Roth MKM | Philip Shen | → $40 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 2162.06% | Roth MKM | Jonathan Aschoff | $12 → $40 | Maintains | Buy | Get Alert |
| 05/19/2022 | Buy Now | 408.96% | HC Wainwright & Co. | Yi Chen | $240 → $180 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Bio-Path Hldgs (BPTH) stock?
The latest price target for Bio-Path Hldgs (NASDAQ:BPTH) was reported by Roth MKM on July 8, 2024. The analyst firm set a price target for $20.00 expecting BPTH to rise to within 12 months (a possible 1031.03% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bio-Path Hldgs (BPTH)?
The latest analyst rating for Bio-Path Hldgs (NASDAQ:BPTH) was provided by Roth MKM, and Bio-Path Hldgs reiterated their buy rating.
When was the last upgrade for Bio-Path Hldgs (BPTH)?
There is no last upgrade for Bio-Path Hldgs
When was the last downgrade for Bio-Path Hldgs (BPTH)?
There is no last downgrade for Bio-Path Hldgs.
When is the next analyst rating going to be posted or updated for Bio-Path Hldgs (BPTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Path Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Path Hldgs was filed on July 8, 2024 so you should expect the next rating to be made available sometime around July 8, 2025.
Is the Analyst Rating Bio-Path Hldgs (BPTH) correct?
While ratings are subjective and will change, the latest Bio-Path Hldgs (BPTH) rating was a reiterated with a price target of $20.00 to $20.00. The current price Bio-Path Hldgs (BPTH) is trading at is $1.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.